---
figid: PMC4487054__ol-10-01-0023-g00
figtitle: Signaling of SGK3 and AKT
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4487054
filename: ol-10-01-0023-g00.jpg
figlink: /pmc/articles/PMC4487054/figure/f1-ol-0-0-3182/
number: F1
caption: 'Signaling of SGK3 and AKT. Activation of PI3K leads to phosphorylation of
  PDK1, subsequently leading to phosphorylation and activation of AKT and SGK3. Cell
  survival and cell growth/proliferation: By regulating the downstream targets, SGK3
  and AKT show a parallel function in cell survival (Bcl-xL, BAD, FKHRs, GSK3-β) and
  cell growth/proliferation (GSK3-β, TSC2, PRAS40). SGK3 also induces cell survival
  by downregulating CXCR4 through the interaction with ubiquitin ligase AIP4. SGK3
  mediates ER-positive cancer cells survival by phosphorylating its co-activator,
  FLI-I. Angiogenesis: PI3K signaling pathways involve in the Foxc2-mediated angiogenesis
  process. Inhibition of GSK3-β by PI3K/AKT up-regulates the expression of HIF-1α,
  which induces VEGF transcriptional activation to promote angiogenesis. ○Resistin
  activates PI3K/AKT to increase the interaction with Sp1, resulting in upregulation
  of VEGF expression to promote angiogenesis. ★PI3K/AKT is mediated by Id1 to enhance
  EPC angiogenesis in ovarian cancer. ∆By regulating PI3K/PTEN/AKT/GSK-3β pathway,
  HIV-1 Tat in KSHV vIL-6-induced angiogenesis. SDF-1/CXCR4 receptor ligand system
  up-regulates VEGF expression to promote angiogenesis. Hypothesis: The red arrow
  pathways are our hypothesis: SGK3 may involve in tumor angiogenesis by regulating
  CXCR4 or/and GSK-3β. PI3K, phosphoinositide 3-kinase; PDK1, 3-phosphoinositide-dependent
  kinase 1; AKT, v-akt murine thymoma viral oncogene homolog; SGK3, serum- and glucocorticoid-inducible
  protein kinase 3; Bcl-xL, B-cell lymphoma-extra large; FKHRs, forkhead family of
  transcription factors; BAD, Bcl-2-associated death promoter; FLI-I, flightless-I;
  GSK3-β, glycogen synthase kinase-β; TSC2, tuberous sclerosis factor 2; PTEN, phosphatase
  and tensin homolog; PRAS40, proline-rich AKT substrate of 40 kDa; SDF-1, stromal
  cell-derived factor 1; CXCR4, C-X-C chemokine receptor type 4; HIF1α, hypoxia-inducible
  factor-1α; VEGF, vascular endothelial growth factor; Id1, inhibitor of DNA binding/differentiation
  1; EPC, endothelial progenitor cell; KSHV vIL-6, Kaposi''s sarcoma-associated herpesvirus
  viral interleukin-6; HIV-1, human immunodeficiency virus type 1; Tat, transactivator
  of transcription; ER, estrogen receptor; AIP4, atrophin-1-interacting protein 4;
  FOXC2, forkhead box protein C2; Sp1, specificity protein 1.'
papertitle: SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).
reftext: MINZHI HOU, et al. Oncol Lett. 2015 Jul;10(1):23-26.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.967458
figid_alias: PMC4487054__F1
figtype: Figure
redirect_from: /figures/PMC4487054__F1
ndex: c4c2d9a0-decc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4487054__ol-10-01-0023-g00.html
  '@type': Dataset
  description: 'Signaling of SGK3 and AKT. Activation of PI3K leads to phosphorylation
    of PDK1, subsequently leading to phosphorylation and activation of AKT and SGK3.
    Cell survival and cell growth/proliferation: By regulating the downstream targets,
    SGK3 and AKT show a parallel function in cell survival (Bcl-xL, BAD, FKHRs, GSK3-β)
    and cell growth/proliferation (GSK3-β, TSC2, PRAS40). SGK3 also induces cell survival
    by downregulating CXCR4 through the interaction with ubiquitin ligase AIP4. SGK3
    mediates ER-positive cancer cells survival by phosphorylating its co-activator,
    FLI-I. Angiogenesis: PI3K signaling pathways involve in the Foxc2-mediated angiogenesis
    process. Inhibition of GSK3-β by PI3K/AKT up-regulates the expression of HIF-1α,
    which induces VEGF transcriptional activation to promote angiogenesis. ○Resistin
    activates PI3K/AKT to increase the interaction with Sp1, resulting in upregulation
    of VEGF expression to promote angiogenesis. ★PI3K/AKT is mediated by Id1 to enhance
    EPC angiogenesis in ovarian cancer. ∆By regulating PI3K/PTEN/AKT/GSK-3β pathway,
    HIV-1 Tat in KSHV vIL-6-induced angiogenesis. SDF-1/CXCR4 receptor ligand system
    up-regulates VEGF expression to promote angiogenesis. Hypothesis: The red arrow
    pathways are our hypothesis: SGK3 may involve in tumor angiogenesis by regulating
    CXCR4 or/and GSK-3β. PI3K, phosphoinositide 3-kinase; PDK1, 3-phosphoinositide-dependent
    kinase 1; AKT, v-akt murine thymoma viral oncogene homolog; SGK3, serum- and glucocorticoid-inducible
    protein kinase 3; Bcl-xL, B-cell lymphoma-extra large; FKHRs, forkhead family
    of transcription factors; BAD, Bcl-2-associated death promoter; FLI-I, flightless-I;
    GSK3-β, glycogen synthase kinase-β; TSC2, tuberous sclerosis factor 2; PTEN, phosphatase
    and tensin homolog; PRAS40, proline-rich AKT substrate of 40 kDa; SDF-1, stromal
    cell-derived factor 1; CXCR4, C-X-C chemokine receptor type 4; HIF1α, hypoxia-inducible
    factor-1α; VEGF, vascular endothelial growth factor; Id1, inhibitor of DNA binding/differentiation
    1; EPC, endothelial progenitor cell; KSHV vIL-6, Kaposi''s sarcoma-associated
    herpesvirus viral interleukin-6; HIV-1, human immunodeficiency virus type 1; Tat,
    transactivator of transcription; ER, estrogen receptor; AIP4, atrophin-1-interacting
    protein 4; FOXC2, forkhead box protein C2; Sp1, specificity protein 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXC2
  - ID1
  - PTEN
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - PDK1
  - PDPK1
  - SGK3
  - AKT1
  - AKT2
  - AKT3
  - CXCR4
  - ITCH
  - SP1
  - PSG1
  - DAND5
  - FLII
  - GSK3A
  - GSK3B
  - TSC2
  - SETD2
  - HIF1A
  - BAD
  - AKT1S1
  - Cancer
---
